Skip to main content
. 2017 Oct 20;8(10):280. doi: 10.3390/genes8100280

Table 1.

Summary of the genetic findings in the analyzed patients.

Patient Diagnosis Gene RefSeq Allele 1 (nt ) Allele 1 (prot. §) Reference Allele 2 (nt ) Allele 2 (prot. §) Reference
6 LCA PCYT1A NM_005017 chr3:195966468; c.847C>T p.(R283*) [34] chr3:195975135; c.277G>A p.(A93T) [35]
7 LCA PCYT1A NM_005017 chr3:195966468; c.847C>T p.(R283*) [34] chr3:195975135; c.277G>A p.(A93T) [35]
8 ACHM CNGB3 NM_019098 chr8:87656009; c.1148delC p.(T383fs) [36] chr8:87660049; c.970A>G p.(R324G) this study
9 ACHM CNGB3 NM_019098 chr8:87656009; c.1148delC p.(T383fs) [36] chr8:87660049; c.970A>G p.(R324G) this study
10 LCA CNGB3 NM_019098 chr8:87656009; c.1148delC p.(T383fs) [36] chr8:87645015; c.1285delT p.(S429fs) this study
12 LCA SPATA7 NM_001040428 chr14:88893049; c.749+1G>A p.? [37] chr14:88903937; c.1115A>G p.(E372G) this study
15 EORP CLN3 NM_001042432 chr16:28497785; c.258_259del p.(G187fs) [38] chr16:28497972; c.161-1G>C p.? [38]
16 LCA CRB NM_001193640 chr1:197396689; c.1898C>T p.(T633M) [39] chr1:197404419; c.3091delT p.(C1031fs) [40]
19 EORP RP2 NM_006915 chrX:46713166; c.358C>T p.(R120*) [41] -
21 EORP IQCB1 NM_001023571 chr3:121491506; c.1066C>T p.(R356*) [42] chr3:121491506; c.1066C>T p.(R356*) [42]
22 EORP AIPL1 NM_001033054 chr17:6329101; c.645G>A p.(W215*) [43] chr17:6329101; c.645G>A p.(W215*) [43]
23 LCA CEP290 NM_025114 chr12:88490755; c.3012delA p.(K1004fs) this study chr12:88477704; c.4732G>T p.(E1578*) [44]
24 ACHM CNGA3 NM_001079878 chr2:99013274; c.1587C>A p.(F529L) [45] chr2:99013274; c.1587C>A p.(F529L) [45]
25 LCA GUCY2D NM_000180 chr17:7917236; c.2302C>T p.(R768W) [46] chr17:7917236; c.2302C>T p.(R768W) [46]
27 LCA NMNAT1 NM_022787 chr1:10032184; c.53A>G p.(N18S) [47] chr1:10042461; c.542A>G p.(Y181C) [48]
29 LCA PCYT1A NM_005017 chr3:195966417; c.897+1G>A p.? [34] chr3:195975135; c.277G>A p.(A93T) [35]
31 EORP CEP290 NM_025114 chr12:88449397; c.6916A>T p.(R2306*) this study chr12:88508262; c.1987A>T p.(K663*) [49]
32 EORP IQCB1 NM_001023570 chr3:121527767; c.479_482del p.(I160fs) this study chr3:121515964; c.876+1G>T p.? this study
33 LCA CRB1 NM_001193640 chr1:197237597; c.55_56insT p.(L19fs) [50] chr1:197391051; c.1757G>A p.(C586Y) this study
36 EORP TULP1 NM_001289395 chr6:35467808; c.1286G>A p.(R429Q) [51] chr6:35467808; c.1286G>A p.(R429Q) [51]
37 EORP CRB1 NM_001193640 chr1:197390271; c.977G>A p.(C326Y) [52] chr1:197390271; c.977G>A p.(C326Y) [52]
39 ACHM PDE6C NM_006204 chr10:95415598; c.2017G>T p.(D673Y) this study chr10:95415598; c.2017G>T p.(D673Y) this study
40 ACHM CNGA3 NM_001079878 chr2:99012747; c.1060C>T p.(P354S) [53] chr2:99012747; c.1060C>T p.(P354S) [53]
41 LCA RPGRIP1 NM_020366 chr14:21762833; c.86-3T>G p.? this study chr14:21793399; c.2225_2226del p.(G742fs) this study
42 LCA GUCY2D NM_000180 chr17:7912823; c.1669-1G>A p.? this study chr17:7912823; c.1669-1G>A p.? this study

LCA: Leber congenital amaurosis; ACHM: achromatopsia; EORP: early onset retinitis pigmentosa; nt: nucleotide; No pathogenic variants were identified in the following LCA (pt. 1, 2, 3, 4, 5, 11, 17, 30, 38) and EORP patients (pt. 13, 18, 20, 28, 35, 43). In the LCA patients 14, 26, and 34 only a single heterozygous mutation was identified in the CEP290 gene (Table S2). Nucleotide variation; § Predicted protein change.